Exenatide and rare adverse events.
Cure
Pablo
P
Pileggi
Antonello
A
Alejandro
Rodolfo
R
D000328:Adult; D001630:Bezoars / Q000175:diagnosis / Q000209:etiology*; D003922:Diabetes Mellitus, Type 1 / Q000150:complications / Q000188:drug therapy* / Q000601:surgery; D016099:Endoscopy, Gastrointestinal; D000077270:Exenatide; D005260:Female; D018589:Gastroparesis / Q000209:etiology*; D052216:Glucagon-Like Peptide 1 / Q000031:analogs & derivatives*; D006801:Humans; D007004:Hypoglycemic Agents / Q000009:adverse effects* / Q000627:therapeutic use; D016381:Islets of Langerhans Transplantation; D016030:Kidney Transplantation; D010455:Peptides / Q000009:adverse effects* / Q000627:therapeutic use; D014688:Venoms / Q000009:adverse effects* / Q000627:therapeutic use
D007004:Hypoglycemic Agents; D010455:Peptides; D014688:Venoms; D052216:Glucagon-Like Peptide 1; D000077270:Exenatide